TY  - GEN
AU  - Psaty,Bruce M
AU  - Lumley,Thomas
TI  - Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs
SN  - 1538-3598
PY  - 2008///0328
KW  - Azetidines
KW  - therapeutic use
KW  - Biomarkers
KW  - Clinical Trials as Topic
KW  - Drug Approval
KW  - Ezetimibe
KW  - Humans
KW  - Hypolipidemic Agents
KW  - Quinolines
KW  - Risk
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1001/jama.299.12.1474
ER  -